Testosterone Nasal Gel Market

Testosterone Nasal Gel Market Outlook (2024 to 2034)

As per a new study published by Fact.MR, the global testosterone nasal gel market is analyzed at US$ 145.36 million in 2024 and is forecasted to increase at a 7.7% CAGR to touch US$ 306.08 million by the end of 2034.

The market for testosterone nasal gel is growing due to the rising number of diagnoses of hypogonadism, or low testosterone levels. More individuals are seeking treatment for symptoms, such as exhaustion, decreased libido, and muscle weakness because of aging populations and lifestyle factors, including stress, poor food, and lack of exercise leading to lower testosterone levels.

The use of nasal gels as a therapy option is driven by the growing need for testosterone replacement medicines. An easy and non-invasive substitute for conventional testosterone treatments, including injections and transdermal patches is testosterone nasal gels.

Because it is easy to use and applied through the nasal mucosa, it does not require needles or patches, which improves patient adherence to treatment and makes the therapy appealing to people looking for a more straightforward approach.

Bioavailability and quick absorption of testosterone are improved by developments in nasal gel formulations. Because nasal gels are made to absorb through the nasal mucosa more quickly, they release testosterone gradually, resulting in more stable blood testosterone levels. Patient satisfaction and treatment efficacy are enhanced by this innovation.

The North American region is forecasted to account for 36.7% of the global market share in 2024 due to its established healthcare system and strong awareness of low testosterone levels. The requirement for testosterone replacement treatments is high in the United States, where a sizable section of the population has been diagnosed with hypogonadism.

Based on the distribution channel, sales from hospital pharmacies are estimated to reach US$ 66.68 million in 2024 because they are essential for treating complicated medical diseases, such as hypogonadism. For individuals who need expert advice and specialized therapy due to severe or confirmed testosterone shortages, hospitals are important points of care.

The hormone testosterone is in charge of the development of male sex organs, male fertility, spermatogenesis, and secondary characteristics. Testosterone nasal gels are used for the treatment of conditions, such as hypogonadism. In this condition, the body does not make sufficient natural testosterone. The market is mainly driven by the prevalence of hypogonadism, new product launches, and collaborations among the players.

What is Driving Demand for Testosterone Nasal Gels?

For the treatment of hypogonadism and other conditions, including Klinefelter syndrome, testosterone replacement therapy is given. During this therapy, supplements containing testosterone are administrated.

The major factors driving the demand for testosterone nasal gels are the rise in the prevalence of hypogonadism, new product launches, and collaborations among the players. According to a report, Klinefelter syndrome is one of the most common chromosomal disorders in newborns resulting in 1 in every 500 - 1000 newborns.

The prevalence of hypogonadism is common among the older male population above 60 years of age. The increasing aging population also acts as a driver for the testosterone nasal gel market.

The advantages offered by the testosterone nasal gel over the injectable form are also huge. This includes a less invasive delivery method, self-administered medications, early-onset, and others. These advantages act as a driver for the market resulting in the surge in demand for testosterone nasal gels during the forecast period.

Regional Outlook for Testosterone Nasal Gels

The market is dominated by the North American region. This is due to the presence of the major player in the market. Natesto is the only FDA-approved testosterone nasal gel and is manufactured by Acerus Pharmaceuticals Corporation situated in Canada. To make sales globally, the company collaborates with other companies for marketing its product globally.

For instance, Acerus Pharmaceuticals Corporation in collaboration with Hyundai Pharm Co. launched Natesto in South Korea. Apart from this hypogonadism affects approximately 4 to 5 million males in the U.S. These factors are responsible for growth in this region.

Who are the Key Manufacturers and Suppliers of Testosterone Nasal Gels?

Some of the leading manufacturers operating in the testosterone nasal gels include

• Acerus Pharmaceuticals Corporation
• Hyundai Pharm Co.
• Endo Pharmaceuticals Inc.
• AbbVie Inc.
• Bristol-Myers Squibb
• Aceto Corporation
• Noven Pharmaceuticals, Inc.
• Endo Pharmaceuticals

Testosterone Nasal Gel Market Report Highlights:

• Detailed overview of the parent market
• Changing market dynamics in the industry
• In-depth market segmentation
• Historical, current, and projected market size in terms of volume and value
• Recent industry trends and developments
• Competitive landscape
• Strategies of key players and products offered
• Potential and niche segments, geographical regions exhibiting promising growth
• A neutral perspective on market performance
• Must-have information for market players to sustain and enhance their market footprint